CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Plasma

The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.

Subtype terms (1)

More specific conditions that are subtypes of Plasma in the MeSH hierarchy.

  • Platelet-Rich Plasma

    13 drugs (7 approved, 6 experimental)

Drugs by status

Phase 4 trials (11)

  • propofol
  • alpha-lipoic acid
  • human factor ix complex (prothrombin complex concentrate)
  • potassium chloride
  • sodium acetate
  • zinc dichloride
  • blood plasma
  • sodium chloride
  • ertapenem
  • hydroxyethyl starch
  • magnesium

Phase 3 trials (7)

  • tacrolimus
  • Filgrastim
  • mycophenolate
  • cyclophosphamide
  • fludarabine
  • b multivitamins
  • COVID-19 convalescent plasma

Phase 2 trials (5)

  • lenalidomide
  • enalapril
  • folic acid
  • daratumumab
  • hdp-101

Phase 1 trials (4)

  • vitamin c
  • sufentanil
  • abiraterone
  • metoprolol

Other trials (7)

  • autologous plasma
  • venofundin
  • amlodipine
  • lamivudine
  • zidovudine
  • hydrochlorothiazide
  • lisinopril

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.